Phrenic long-term facilitation (pLTF) is a form of hypoxia-induced spinal respiratory motor plasticity that requires new synthesis of brain derived neurotrophic factor (BDNF) and activation of its high-affinity receptor, tropomyosin receptor kinase B (TrkB). Since the cellular location of relevant TrkB receptors is not known, we utilized intrapleural siRNA injections to selectively knock down TrkB receptor protein within phrenic motor neurons. TrkB receptors within phrenic motor neurons are necessary for BDNF-dependent acute intermittent hypoxia-induced pLTF, demonstrating that phrenic motor neurons are a critical site of respiratory motor plasticity.
Introduction
Neuroplasticity has long been associated with conscious memory formation and motor learning in mammals (Ramón y Cajal, 1907; Hebb, 1949; Bliss and Lomo, 1973; Bailey et al., 1996) , but has only recently been appreciated in the neural system controlling breathing (Mitchell and Johnson, 2003; Feldman et al., 2003) . Although several examples of spinal motor neuron plasticity exist in invertebrate motor systems (Glanzman, 2009; Tauc, 1965a, 1965b) , mammalian motor neurons have traditionally been portrayed as inflexible relays between the brain and muscles actuating movements (Eccles and Sherrington, 1930) .
One stimulus for eliciting respiratory plasticity is low oxygen (hypoxia), such as the carotid body plasticity observed following sustained or intermittent hypoxia (Kumar and Prabhakar, 2012) , and spinal motor plasticity following acute intermittent hypoxia (AIH; Bach and Mitchell, 1996; Baker and Mitchell, 2000) . Although spinal respiratory motor plasticity is suspected to arise from cellular mechanisms within respiratory motor neurons (Baker-Herman and Mitchell, 2002; Mitchell et al., 2001; Feldman et al., 2003) , this hypothesis has not been adequately tested. Previous work using adeno-associated viruses to deliver TrkB protein to phrenic motor neurons demonstrated that phrenic motor neuron TrkB expression promotes recovery following C2 spinal hemisection Gransee et al., 2013) , but this study did not evaluate other, non-injury related forms of phrenic motor plasticity.
Considerable effort has been focused on understanding cellular and synaptic mechanisms of AIH-induced phrenic long-term facilitation (pLTF), and we know that it: 1) is initiated by spinal, serotonin type 2 receptor activation (5-HT2; Baker-Herman and Mitchell, 2002; Fuller et al., 2001; Kinkead et al., 1998; MacFarlane et al., 2011) ; 2) requires protein kinas C-θ activity within phrenic motor neurons (Devinney et al., 2015) ; 3) requires new synthesis of spinal brain derived neurotrophic factor (BDNF; Baker-Herman et al., 2004) ; and 4) requires ERK/MAP kinase signaling (Hoffman et al., 2012) . Although new BDNF synthesis is necessary and sufficient for AIH-induced pLTF (Baker-Herman et al., 2004) , the involvement of its high affinity receptor, tropomyosin receptor kinase B (TrkB), has not been conclusively demonstrated. Previous studies used a non-selective drug (K252a; Baker-Herman et al., 2004; Ruegg and Burgess, 1989) to block tyrosine kinase activity throughout the cervical spinal region, but the cell type hosting the relevant BDNF/ TrkB signaling could not be determined. Here, we tested the hypothesis that phrenic motor neuron TrkB protein expression is necessary for BDNF-dependent phrenic long-term facilitation following AIH. We demonstrate that intrapleural administration of siRNAs targeting TrkB mRNA knocks down TrkB protein in the phrenic motor nucleus, but not in nearby spinal regions expected to contain pre-phrenic interneurons. Since, TrkB knock-down with intrapleural siRNAs abolishes AIHinduced pLTF, AIH-induced pLTF results from spinal motor neuron plasticity.
Materials and methods

Animals
Adult male Sprague-Dawley rats (2-5 months old; colony 218A, Harlan; Indianapolis, IN) were studied. Rats were double-housed with food and water ad libitum, in a 12 h light/dark cycle with controlled humidity and temperature. The University of Wisconsin Institutional Animal Care and Use Committee approved all animal procedures/protocols.
2.2. siRNA and cholera toxin B fragment delivery siRNAs were prepared per manufacturer instructions (Dharmacon Inc.). Pools of four Accell-modified siRNA (21 base pairs) duplexes targeting different mRNA sequences were used; each duplex was either non-targeting (siNT) or targeting TrkB (siTrkB). siTrkB duplexes targeted the following sequences: GCUUAAAGUUUGUGGCUUA, CUAAUGGCCAAGAAUGAAU, GUAUCAGCUAUCAAACAAC, and GCACCAACCAUCACAUUUC. Accell-modified siRNAs were used because they preferentially transfect neurons (Nakajima et al., 2012) .
Each pool was suspended in Dharmacon siRNA buffer at a concentration of 5 μM, aliquoted and stored at −20°C. Prior to intrapleural injections, 20 μl of siRNA was added to 6 μl of 5× siRNA buffer (Dharmacon), 3.2 μl of Oligofectamine Transfection Reagent (Invitrogen), 0.8 μl of RNAase free H 2 O (final siRNA concentration of 3.33 μM) and mixed for 20 min prior to injection, thus enabling siRNAs to complex with the transfection reagent.
Cholera toxin B (CtB) fragment and siRNAs were injected intrapleurally similar to earlier reports to respectively back-label phrenic motor neurons (Mantilla et al., 2009 ) and induce RNA interference . Anesthesia was induced with 5% isoflurane in 100% O 2 , and then maintained via nose cone (3.5% isoflurane, 100% O 2 ). 12.5 μl of CtB (2 μg/μl in sterile H 2 O) was loaded into a 25 μl Hamilton syringe attached to a 6 mm sterile needle before bilateral injections (2 × 12.5 μl of 2 μg/μl total) at the 5th intercostal space anterior axillary line 7 days prior to tissue harvest. Intrapleural siRNAs were delivered daily as 30 μl injections bilaterally (2 × 30μl of 5 μM siRNA) from a 50 μl Hamilton syringe 3, 2 and 1 day prior to tissue harvest or neurophysiology experiments (outlined in Fig. 1A ). This technique was adapted from previous reports using intrapleural siRNA injections to knockdown gene expression within phrenic motor neurons Devinney et al., 2015) . After injections, isoflurane was discontinued and chest movements were monitored for signs of distress and/or pneumothorax (none observed). Rats were housed and monitored daily until used for neurophysiology or immunohistochemistry (IHC) experiments.
Experimental groups
Four rat groups were studied for neurophysiology experiments: 1) siTrkB + AIH (n = 7); 2) siNT + AIH (n = 5); 3) vehicle + AIH (n = 11); 4) vehicle + normoxia (Nx). Normoxia control groups experienced persistent ventilation with normoxia air (50% O 2 + 2% CO 2 + 48% N 2 ). 3 separate rat groups were used for IHC analysis. The IHC groups received intrapleural CtB and siRNA injections (outlined above) but did not undergo the neurophysiology protocol (outlined below). The IHC groups were: 1) siTrkB (n = 6); 2) siNT (n = 6); 3) vehicle (n = 6). 50 total rats were used in this study. (1), rats were given either Nx or AIH, and assessed for pLTF (2). B) In compressed phrenic neurograms, rats given vehicle (top) or siNT (second trace) exhibit pLTF following AIH; in contrast, rats receiving siTrkB (third trace) did not express pLTF following AIH. Control trace of rats receiving intrapleural vehicle injections without AIH (bottom) also did not exhibit pLTF. C) AIH increases phrenic burst amplitude in control (■; n = 11) and siNT rats (•; n = 5), but not siTrkB rats (○; n = 7), relative to Nx (▲; n = 9) controls 60-min post-AIH. D) AIH elicited small increases in frequency within vehicle (■) and siNT ( 
Neurophysiology experiments
Anesthetic induction (5% isoflurane in 100% O 2 ) occurred in a closed chamber, followed by maintenance with a nose cone (3.5% isoflurane in 50% O 2 ; 2% CO 2 ; 48% N 2 ). Rats were tracheotomized and pump ventilated for the duration of experiments (2.5 ml, Rodent Ventilator, model 683; Harvard Apparatus; South Natick, MA, USA). Rats were bilaterally vagotomized to eliminate lung stretch-receptor feedback and ventilator entrainment, and the right femoral artery was catheterized for measurement of arterial blood pressure and to allow for sampling of arterial blood for blood gas analysis. The left phrenic nerve was isolated via a dorsal approach, cut distally, de-sheathed, submerged in mineral oil and placed on bipolar silver wire electrodes. After nerve dissection rats were slowly converted to urethane anesthesia (1.8 g/kg, i.v. tail vein). Supplemental urethane was provided if rats showed a positive toe pinch response (any purposeful movement or cardiorespiratory response to toe pinch). After ensuring adequate anesthesia, rats were paralyzed with pancuronium bromide (2.5 mg/kg, i.v.). Body temperature (measured via rectal probe; Traceable™, Fisher Scientific; Pittsburgh, PA, USA) was maintained within ± 0.3°C of baseline (37.5°C) with a custom temperature-controlled surgical table. A flow-through capnograph with sufficient response time to measure end-tidal CO 2 in rats (Capnogard, Novametrix; Wallingford, CT; USA) was used to monitor CO 2 . A heparinized plastic capillary tube (Radiometer Medical Aps, Copenhagen, Denmark; 250 × 125 μl cut in half) was used to monitor temperature corrected arterial blood gases (PaO 2 and PaCO 2 ), pH and base excess (ABL 800Flex, Radiometer; Copenhagen, Denmark). Intravenous fluid infusions (1:1.7:5 by volume of NaHCO 3 /Lactated Ringer's/Hetastarch; 1.5-2.2 ml/h) were used to maintain blood pressure, acid/base and fluid balance.
Phrenic nerve activity was amplified (×10,000: A-M Systems, Everett, WA), band-pass filtered (100 Hz to 10 kHz), full-wave rectified, processed as a continuous moving average (CWE 821 filter; Paynter, Ardmore, PA: time constant 50 ms) and analyzed using a WINDAQ data-acquisition system (DATAQ Instruments, Akron, OH). Peak integrated phrenic burst frequency and amplitude were analyzed in 60 s bins prior to blood samples. Data were included only if PaCO 2 was maintained within ± 1.5 mm Hg of baseline levels (set by recruitment threshold for each rat; see below), base excess was within ±3 mEq/L of 0.0, and MAP decreased b30 mm Hg of baseline (approx. 120 mm Hg) values. Physiological variables are summarized within Table 1 . There were no consistent differences between groups within a single time point, or within a single group at different time points. Nerve burst amplitude is expressed as a percent change from baseline; frequency is expressed as an absolute change from baseline (bpm). 1 hour after conversion to urethane anesthesia the CO 2 apneic threshold was determined by reducing inspired CO 2 and/or increasing ventilator frequency until phrenic nerve activity ceased. Baseline was then established by maintaining end-tidal PACO 2 1-2 mm Hg above the subsequent recruitment threshold -the PACO 2 at which phrenic inspiratory activity resumes following apnea (Bach and Mitchell, 1996) . Rats were exposed to normoxia gas levels to establish 20 min of stable baseline nerve recordings. A blood sample was drawn to establish baseline blood gas values, and the rats were then exposed to either continuous normoxia or AIH (3, 5 min episodes of 10% FIO 2 , 5 min intervals). Subsequent arterial blood samples were taken at 15, 30 and 60 min post-AIH. Electrophysiological data were analyzed using a 2-way ANOVA with repeated measures design and a Fisher LSD post-hoc analysis (SigmaStat 2.03).
Immunohistochemistry and immunofluorescence
Following siRNA and CtB injections, 18 rats (n = 6 per group; siTrkB, siNT, and vehicle) were euthanized and perfused transcardially with 1 ml/g chilled 0.01 M PBS followed by 1 ml/g chilled 4% paraformaldehyde (PFA) at a pH of 7.4. The rats were shelf rats that did not receive any surgery related to neurophysiology experiments. The spinal cords were harvested and placed into 4% PFA for 8 h at 4°C. The tissues were then transferred to 20% sucrose followed by 30% sucrose until sinking. 40 μm transverse slices were cut using a microtome (SM2000R Leica, Buffalo Grove, IL) from C3-C5 and placed into antifreeze solution (30% glycerol; 30% ethylene glycol; 40% 0.1 M PBS). For each group, 8 slices from 6 rats (46 total slices per group) were selected for staining (slices were at least 200 μm apart). Slices were washed with 0.05 M tris-buffered saline with 0.1% Triton-X (TBS-Tx) and blocked with 1.0% bovine serum albumin (BSA) for 1 h. The tissues were stained with rabbit anti-TrkB (Santa Cruz Biotech) and goat anti-CtB (Millipore) at room temperature for 16 h. Using western blot and IHC, a previous study has confirmed the selectivity of the TrkB antibody (Krause et al., 2008) . Slices were washed with TBS-Tx and subsequently stained with conjugated donkey anti-goat Alexa Fluor 595 (Invitrogen) and conjugated donkey anti-rabbit Alexa Fluor 488 (Invitrogen) for 2 h at room temperature. Tissue slices were washed a final time with TBS and mounted with coverslip and an anti-fade solution (Invitrogen). Slices were imaged on an epifluorescence confocal microscope at 20× using Nikon EZ-C1 software. The images were localized onto the phrenic nuclei cluster bilaterally via CtB identification and a reference control region (area immediately to the central canal of C3-C6) for each slice. Since TrkB is often concentrated in dendrites versus the cell soma (Kovalchuk et al., 2002) , and CtB retrograde tracer does not reach the ; circumference: 314 μm) encompassing CtB labeled phrenic motor neurons at C3-C5. The same dimensions were used for the medio-dorsal region of interest as well. While the total number of CtB labeled neurons was consistent among groups, CtB immunofluorescence within individual motor neurons decreased in rats treated with siRNA targeting TrkB mRNA, consistent with other studies showing that functional siRNAs can interrupt transport of retrograde tracers (Murashov et al., 2007) . Thus, we did not attempt to normalize TrkB immunofluorescence to CtB staining, but relied on an "area of interest" measurement centered on CtB labeled cells, restricting analysis to the phrenic motor nucleus.
TrkB quantification was done with NIH Image J Software. The siNT rat group was used as a reference (control); thus, changes in TrkB immunofluorescence in other groups were expressed relative to siNT rats within a given batch. Staining was completed in 2 batches with equal representation of samples from each group in each batch (vehicle, siNT and siTrkB). One way ANOVA was used, with a Fisher's LSD post hoc test to compare individual groups.
Results
Intrapleural siRNAs targeting TrkB abolish phrenic long-term facilitation
To confirm that TrkB is necessary for pLTF, and to test the hypothesis that the relevant TrkB is within phrenic motor neurons (versus pre-synaptic neurons or nearby glia), we utilized intrapleural injections of small interfering RNAs targeting TrkB mRNA (siTrkB) to selectively knock down TrkB within phrenic motor neurons .
Rats pretreated with siTrkB (n = 7), siNT (n = 5) or vehicle injections (n = 11; Fig. 1A ), were exposed to AIH and assessed for pLTF expression (Devinney et al., 2013; Fuller et al., 2001; Baker-Herman and Mitchell, 2008) . In both siNT and vehicle treated rats, pLTF was robust one-hour post-AIH (Fig. 1B-C) . In contrast, intrapleural siTrkB injections abolished pLTF (Fig. 1B-C) . While AIH elicited a small increase in phrenic burst frequency within siNT and vehicle rats, siTrkB rats did not express frequency LTF (Fig. 1C) . Typically after AIH, changes in respiratory motor output are expressed in burst amplitude with inconsistent and highly variable changes in burst frequency (Fig. 1D) . Since frequency LTF is small and inconsistent in this preparation (BakerHerman and Mitchell, 2008) , we did not explore it further. An additional group of Nx control rats received intrapleural vehicle injections without AIH (n = 9; Fig. 1B-D) . Nx control rats demonstrated no significant drift in phrenic burst amplitude or frequency, confirming that pLTF results from AIH versus intrapleural injections, surgical procedures or other non-specific effects.
Intrapleural siTrkB selectively down-regulates TrkB protein in phrenic motor neurons
To confirm TrkB protein knockdown within identified phrenic motor neurons shelf rats received intrapleural injections of the CtB retrograde tracer (Mantilla et al., 2009 ) and either siTrkB, siNT, or vehicle. While TrkB immunofluorescence was abundant near CtB labeled phrenic motor neurons ( Fig. 2A-B ) of siNT and vehicle treated rats (Fig. 2C-D) , siTrkB rats had relatively reduced TrkB expression (23% reduction relative to siNT and vehicle control groups; Fig. 2E-F; G) . Within the region medio-dorsal to the phrenic motor nucleus, TrkB immunofluorescence was the same between all groups (Fig. 2H) ; this region contains at least some spinal phrenic interneurons (Lane, 2011) , suggesting that trans-synaptic transmission of siTrkB did not occur.
Consistent with a localized knockdown of protein expression within phrenic motor neurons, we show that intrapleural siTrkB: 1) decreases TrkB immunofluorescence within phrenic motor neurons but not nearby regions that contain phrenic interneurons; and 2) abolishes pLTF expression without affecting the short-term hypoxic response, CO 2 apneic threshold or baseline nerve activity (Fig. 3A-C) .
Discussion
Although there has been considerable research on cellular mechanisms of synaptic plasticity in the brain, far less attention has been given to spinal motor plasticity in mammals, particularly mechanisms of plasticity in spinal motor neurons. Here we confirm the hypothesis that the relevant TrkB receptors for AIH-induced pLTF are localized within phrenic motor neurons.
BDNF/TrkB signaling and pLTF
BDNF plays a key role in neurotransmission and activity-dependent synaptic plasticity (Lessmann et al., 1994; Kang and Schuman, 1995; Levine et al., 1995; Berninger and Poo, 1996; Korte et al., 1996; Patterson et al., 1996; Li et al., 1998) . Interrupting signaling via the high-affinity BDNF receptor TrkB prevents breathing recovery following cervical spinal hemisection , suggesting an important role of spinal BDNF/TrkB in spontaneous functional recovery following injury. We now show that TrkB activation within phrenic motor neurons is necessary for a well-studied form of respiratory neuroplasticity, BDNF dependent AIH-induced pLTF. We postulate that AIH triggers serotonin release and 5HT2 receptor activation on phrenic motor neurons Baker-Herman and Mitchell, 2002) , activating PKC-θ (Devinney et al., 2015) and ERK/MAP kinases (Hoffman et al., 2012) , initiating new BDNF synthesis (Baker-Herman et al., 2004) and release followed by autocrine TrkB activation (this study). The ultimate outcome of these signaling events is a long-term increase in phrenic motor output, possibly by enhancing glutamate receptor function ( Fig. 4 ; Fuller et al., 2000; McGuire et al., 2008) .
Intrapleural siRNAs selectively target phrenic motor neurons
It is difficult to completely rule out trans-synaptic siRNA exchange following intrapleural injections. In cultured cells, some reports suggest that neurons can regulate astrocyte gene expression via exosome mediated micro-RNA transfer (Morel et al., 2013) . However, since intrapleural siTrkB down-regulates TrkB protein around CtB labeled phrenic motor neurons (23% reduction relative to siNT and vehicle control groups; Fig. 2G ), but not in dorsomedial regions (Fig. 2H) known to contain synaptically-coupled phrenic interneurons (Lane, 2011) , we find no support for the idea that effective trans-synaptic siRNA exchange occurred within this in vivo preparation. Our results are consistent with the report that intrapleural injections of fluorescent siRNAs result in fluorescence within identified phrenic motor neurons and not in adjacent neurons or glia .
Since intrapleural siTrkBs do not affect CO 2 apneic threshold, baseline voltage or baseline frequency (Fig. 3A-C) , siTrkB does not appear to reach the brainstem with sufficient concentration to affect relevant BDNF/TrkB signaling in brainstem regions mediating chemoreflexes or respiratory rhythm generation (Thoby-Brisson et al., 2003) . In a previous study from our laboratory, we used intrapleural siRNAs targeting PKC-θ (Devinney et al., 2015) . In this study, ventral spinal PKC-θ was knocked down N 50% and AIH-induced pLTF was abolished, yet this treatment had no effect on XII LTF (Devinney et al., 2015) . These results provide additional evidence supporting the idea that intrapleural siRNA effects are localized to spinal motor neurons (or at least motor nuclei). Although other respiratory motor pools associated with the plural space (e.g. intercostal) may be affected by intrapleural siTrkB injections (Mantilla et al., 2009) , there is no evidence that direct connections from intercostal to phrenic motor neurons exist and these motor neurons are unlikely to affect pLTF assessed directly in the phrenic nerve. Collectively, data presented here and relevant literature support the hypothesis that intrapleural siRNA injections target spinal respiratory motor neurons, and not pre-synaptic or peri-synaptic elements of the cellular network. Intrapleural siRNA injections appear to be a powerful and relatively non-invasive experimental tool to manipulate gene expression within spinal respiratory motor neurons.
These studies increase our understanding of plasticity in an interesting and essential population of constitutively active motor neurons. In specific, they provide additional support for the idea that BDNF-dependent AIH-induced pLTF requires TrkB activation within phrenic motor neurons. Thus, phrenic motor neurons appear to "learn" from experience, and are a major site of plasticity in respiratory motor control. Beyond the immediate implications of this study, the efficacy of intrapleural siRNA injections suggests that this approach Devinney et al., 2015) has powerful experimental advantages in the investigation of new molecules and their biological roles within phrenic and intercostal motor neurons. From a different perspective, intrapleural siRNAs may have potential as a therapeutic intervention to aid in the treatment of severe clinical disorders that cause respiratory and non-respiratory somatic motor deficits (see Mitchell, 2007; Dale et al., 2014; Devinney et al., 2015) .
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The authors declare no competing financial interests. Fig. 2 . TrkB protein (green) expressed in CtB-labeled phrenic motor neurons (red) of shelf rats injected with vehicle control (A-B; n = 6), siNT (C-D; n = 6), or siTrkB (E-F; n = 6). Phrenic motor nucleus (dashed circle) and medio-dorsal control (solid circle) regions are outlined as noted. siTrkB reduced TrkB immunofluorescence within the phrenic motor nucleus relative to vehicle control rats (G). Immunofluorescence of TrkB in the phrenic motor nucleus (G) decreased 23% (77% ± 1.6% of siNT) within rats injected siTrkB, but not rats injected with vehicle. Despite a reduction of TrkB immunofluorescence near the phrenic motor nucleus of rats injected with siTrkB, TrkB immunofluorescence was unchanged in the control region (H). Means (normalized to average siNT TrkB immunofluorescence) ± SEM. * p b 0.001 versus siNT. Fig. 3 . There were no significant differences among experimental groups (as described in Fig. 1 ) in: A: non-normalized voltage of the integrated phrenic neurogram during baseline conditions; B: CO 2 apneic or recruitment thresholds; or C: baseline frequency. Values expressed as means ± SEM. All p N 0.05.
